Blood irradiation therapy

Last updated

Blood irradiation therapy
Specialty Hematology

Blood irradiation therapy is an alternative medical procedure in which the blood is exposed to low-level light (often laser light) for therapeutic reasons. [1] The practice was originally developed in the United States, [1] but most recent research on it has been conducted in Germany (by UV lamps) and in Russia (in all variants). [2] [3] [4] [5] Low-level laser therapy has been tested for a wide range of conditions, but rigorous double-blinded studies have not yet been performed. [6] Furthermore, it has been claimed that ultraviolet irradiation of blood kills bacteria by DNA damage and also activation of the immune system. Blood irradiation therapy is highly controversial, and has fallen from mainstream use since its heyday in the 1940s and 1950s. [1]

Contents

Blood irradiation therapy can be administered in three ways: extracorporeally, transcutaneously, and intravenously. The extracorporeal (outside the body) method removes blood from the body and irradiates it in a special cuvette (tube). This method is used for the ultraviolet (UV) blood irradiation (UVBI) by UV lamps. In the transcutaneous method, the radiation goes through the skin, by placing a device on the outside of the skin. In the intravenous method, a device is inserted into a large blood vessel. The laser light is monochromatic.

It is not related to the practice of gamma irradiation of blood in transfusion medicine.

History

In 1928, Dr. Emmet Knott and a medical student named Lester Edblom received a United States patent for a "Means for Treating Blood-Stream Infection" that incorporated a rudimentary ultraviolet bulb, vacuum extraction system and a cuvette. The "Knott Hemo-Irradiator" was used from the 1930s through the 1950s on patients with multiple infectious diseases.

George P Miley at the Hahnemann Hospital in Philadelphia, Pennsylvania, published a series of articles on the use of the procedure in the treatment of thrombophlebitis, staphylococcal sepsis, peritonitis, botulism, poliomyelitis, non-healing wounds, and asthma.

One of the best known and most comprehensive set of studies was published in 1947 by Dr. George Miley and Dr. Jens A Christensen (from the Blood Irradiation Clinic of the Hahnemann Medical College and Hospital of Philadelphia, Pennsylvania). The authors studied 445 cases of acute pyogenic infections and 74 cases of virus and virus-like infections. Findings included the following: sulfonamide-resistant and penicillin-resistant infections have responded to the treatment. Further finding included: "We have observed that toxemias due to various virus and virus-like infections subside rapidly …” Some of the more impressive results included cases involving septic infection, 57 out of 57 cases recovered. In treating peritonitis, 16 out of 18 patients recovered. With puerperal sepsis, 14 out of 14 patients recovered. With thrombophlebitis, 34 out of 34 recovered. The authors emphasized the need to follow the protocol set for by Knott. Of importance, this protocol included the use of a chamber or cuvette with a flat quartz surface. 

Henry A Barrett at the Willard Parker Hospital in New York City, in 1940 reported on 110 cases including a number of infections. Twenty-nine different conditions were described as responding including the following: infectious arthritis, septic abortion, osteoarthritis, tuberculosis glands, chronic blepharitis, mastoiditis, uveitis, furunculosis, chronic paranasal sinusitis, acne vulgaris, and secondary anemia. [7]

This procedure fell out of favor in the late 1950s, at a time when antibiotics and the polio vaccine were becoming widely used. [7] Since then it has been sidelined as a type of alternative and complementary medicine. [1]

The U.S. Food and Drug Administration (FDA) has approved one type of this treatment [8] [9] for T cell lymphoma. This particular process was developed by a team at Yale, led by Richard Edelson who developed a photopheresis machine. This machine separates the white and red blood cells. The white cells are then routed into a blood chamber, where those cells are subjected to UV light from the UVA part of the spectrum. This process uses a photosensitizing agent which enhances the effectiveness of the light. [10]  Observational evidence suggests that photopheresis might be effective in the treatment of graft-versus-host disease, [11] though controlled trials are needed to support this use. [12] [13]

The American Cancer Society lists blood irradiation therapy as one of many types of ineffective cancer treatment fraudulently sold by alternative cancer treatment clinics in Mexico. [14]

Types

Intravenous laser blood irradiation

Intravenous blood irradiation Intravenous Blood Irradiation.JPG
Intravenous blood irradiation

Intravenous or intravascular laser blood irradiation (ILBI) involves the in-vivo illumination of the blood by feeding low level laser light generated by a 1–3 mW helium–neon laser at a wavelength of 632.8 nanometers (nm) into a vascular channel, usually a vein in the forearm, under the assumption that any therapeutic effect will be circulated through the circulatory system. [15] Most often wavelengths of 365, 405, 525 and 635 nm and power of 2.3 mW are used. The technique is widely used at present in Russia, less in Asia, and not extensively in other parts of the world. It is shown that ILBI improves blood flow and its transport activities, therefore, tissue tropism, has a positive effect on the immune system and cell metabolism. [2] [3] [ better source needed ] This issue is subject to skepticism. [2]

Transcutaneous laser blood irradiation

Transcutaneous therapy applies laser light on unbroken skin in areas with large numbers of blood vessels (such as the forearm). Because of the skin acting as a barrier to the blood, absorbing low level laser energy, the power of the laser is often boosted to compensate. [16] The problem can be solved by using pulsed matrix laser light sources. [3]

Extracorporeal irradiation

Extracorporeal irradiation is used only for ultraviolet blood irradiation, that involves drawing blood out through a vein and irradiating it outside of the body. [17]

Though promoted as a treatment for cancer, a 1952 review in the Journal of the American Medical Association [4] and another review by the American Cancer Society in 1970 concluded the treatment was ineffective. [18]

See also

Related Research Articles

<span class="mw-page-title-main">Ultraviolet</span> Form of electromagnetic radiation

Ultraviolet (UV) is a form of electromagnetic radiation with wavelength shorter than that of visible light, but longer than X-rays. UV radiation is present in sunlight, and constitutes about 10% of the total electromagnetic radiation output from the Sun. It is also produced by electric arcs; Cherenkov radiation; and specialized lights; such as mercury-vapor lamps, tanning lamps, and black lights. Although long-wavelength ultraviolet is not considered an ionizing radiation because its photons lack the energy to ionize atoms, it can cause chemical reactions and causes many substances to glow or fluoresce. Many practical applications, including chemical and biological effects, derive from the way that UV radiation can interact with organic molecules. These interactions can involve absorption or adjusting energy states in molecules, but do not necessarily involve heating.

<span class="mw-page-title-main">Neutropenia</span> Abnormally low concentration of neutrophils (a type of white blood cell) in the blood

Neutropenia is an abnormally low concentration of neutrophils in the blood. Neutrophils make up the majority of circulating white blood cells and serve as the primary defense against infections by destroying bacteria, bacterial fragments and immunoglobulin-bound viruses in the blood. People with neutropenia are more susceptible to bacterial infections and, without prompt medical attention, the condition may become life-threatening.

<span class="mw-page-title-main">Multiple myeloma</span> Cancer of plasma cells

Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, anemia, kidney dysfunction, and infections may occur. Complications may include hypercalcemia and amyloidosis.

<span class="mw-page-title-main">Photodynamic therapy</span> Form of phototherapy

Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance, used in conjunction with molecular oxygen to elicit cell death (phototoxicity).

<span class="mw-page-title-main">Sedoreoviridae</span> Family of viruses

Sedoreoviridae is a family of double-stranded RNA viruses. Member viruses have a wide host range, including vertebrates, invertebrates, plants, protists and fungi. They lack lipid envelopes and package their segmented genome within multi-layered capsids. Lack of a lipid envelope has allowed three-dimensional structures of these large complex viruses to be obtained, revealing a structural and likely evolutionary relationship to the cystovirus family of bacteriophage. There are currently 97 species in this family, divided among 15 genera in two subfamilies. Reoviruses can affect the gastrointestinal system and respiratory tract. The name "reo-" is an acronym for "respiratory enteric orphan" viruses. The term "orphan virus" refers to the fact that some of these viruses have been observed not associated with any known disease. Even though viruses in the family Reoviridae have more recently been identified with various diseases, the original name is still used.

<span class="mw-page-title-main">Hematopoietic stem cell transplantation</span> Medical procedure to replace blood or immune stem cells

Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood in order to replicate inside of a patient and to produce additional normal blood cells. It may be autologous, allogeneic or syngeneic.

<span class="mw-page-title-main">Light therapy</span> Therapy involving intentional exposure to sunlight

Light therapy, also called phototherapy or bright light therapy is the exposure to direct sunlight or artificial light at controlled wavelengths in order to treat a variety of medical disorders, including seasonal affective disorder (SAD), circadian rhythm sleep-wake disorders, cancers, and skin wound infections. Treating skin conditions such as neurodermatitis, psoriasis, acne vulgaris, and eczema with ultraviolet light is called ultraviolet light therapy.

<span class="mw-page-title-main">Apheresis</span> Medical techniques to separate one or more components of blood

Apheresis is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is thus an extracorporeal therapy.

<span class="mw-page-title-main">Mycosis fungoides</span> Most common form of cutaneous T-cell lymphoma

Mycosis fungoides, also known as Alibert-Bazin syndrome or granuloma fungoides, is the most common form of cutaneous T-cell lymphoma. It generally affects the skin, but may progress internally over time. Symptoms include rash, tumors, skin lesions, and itchy skin.

Virotherapy is a treatment using biotechnology to convert viruses into therapeutic agents by reprogramming viruses to treat diseases. There are three main branches of virotherapy: anti-cancer oncolytic viruses, viral vectors for gene therapy and viral immunotherapy. These branches use three different types of treatment methods: gene overexpression, gene knockout, and suicide gene delivery. Gene overexpression adds genetic sequences that compensate for low to zero levels of needed gene expression. Gene knockout uses RNA methods to silence or reduce expression of disease-causing genes. Suicide gene delivery introduces genetic sequences that induce an apoptotic response in cells, usually to kill cancerous growths. In a slightly different context, virotherapy can also refer more broadly to the use of viruses to treat certain medical conditions by killing pathogens.

Therapeutic effect refers to the response(s) after a treatment of any kind, the results of which are judged to be useful or favorable. This is true whether the result was expected, unexpected, or even an unintended consequence. An adverse effect is the converse and refers to harmful or undesired response(s). What constitutes a therapeutic effect versus a side effect is a matter of both the nature of the situation and the goals of treatment. No inherent difference separates therapeutic and undesired side effects; both responses are behavioral/physiologic changes that occur as a response to the treatment strategy or agent.

In medicine, photopheresis is a form of apheresis and photodynamic therapy in which blood is subject to apheresis to separate buffy coat from whole blood, chemically treated with 8-methoxypsoralen, exposed to ultraviolet light (UVA), and then returned to the patient. Activated 8-methoxypsoralen crosslinks DNA in exposed cells, ultimately resulting apoptosis of nucleated cells. The photochemically damaged T-cells returned to the patient appear to induce cytotoxic effects on T-cell formation. The mechanism of such “antitumor” action has not been elucidated.

Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) co-infection is a multi-faceted, chronic condition that significantly impacts public health. According to the World Health Organization (WHO), 2 to 15% of those infected with HIV are also affected by HCV, increasing their risk of morbidity and mortality due to accelerated liver disease. The burden of co-infection is especially high in certain high-risk groups, such as intravenous drug users and men who have sex with men. These individuals who are HIV-positive are commonly co-infected with HCV due to shared routes of transmission including, but not limited to, exposure to HIV-positive blood, sexual intercourse, and passage of the Hepatitis C virus from mother to infant during childbirth.

A medical procedure is a course of action intended to achieve a result in the delivery of healthcare.

<span class="mw-page-title-main">Extracorporeal shockwave therapy</span> Ultrasonic, non-invasive, outpatient treatment

Extracorporeal shockwave therapy (ESWT) is a non-invasive, out-patient alternative to surgery for those with many joint and tendon disorders. ESWT sends acoustic shock waves into bone or soft tissue, in effect reinjuring the area on a cellular level and breaking up the scarring that has penetrated tendons and ligaments. The controlled reinjuring of tissue allows the body to regenerate blood vessels and bone cells. The resulting revascularization leads to faster healing and often a return to pre-injury activity levels. It is a treatment using powerful acoustic pulses which is mostly used to treat kidney stones and in physical therapy and orthopedics.

<span class="mw-page-title-main">Liver cancer</span> Medical condition

Liver cancer is cancer that starts in the liver. Liver cancer can be primary or secondary. Liver metastasis is more common than that which starts in the liver. Liver cancer is increasing globally.

<span class="mw-page-title-main">Low-level laser therapy</span> Treatment using irradiation with light of low power intensity

Low-level laser therapy (LLLT), cold laser therapy, photobiomodulation (PBM) or red light therapy is a form of medicine that applies low-level (low-power) lasers or light-emitting diodes (LEDs) to the surface of the body. Whereas high-power lasers are used in laser medicine to cut or destroy tissue, it is claimed that application of low-power lasers relieves pain or stimulates and enhances cell function. The effects appear to be limited to a specified set of wavelengths and new research has demonstrated effectiveness at myopia control. Several such devices are cleared by the United States Food and Drug Administration (FDA), and research shows potential for treating a range of medical problems including rheumatoid arthritis and oral mucositis.

Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating with UV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as “pathogen inactivation” in the industry.

<span class="mw-page-title-main">William A. Haseltine</span> American biologist (born 1944)

William A. Haseltine is an American scientist, businessman, author, and philanthropist. He is known for his groundbreaking work on HIV/AIDS and the human genome.

Mature T-cell lymphoma, also called peripheral T-cell lymphoma, is a group of rare, aggressive lymphomas that develop from mature white blood cells and originate from lymphoid tissues outside of the bone marrow. Mature T-cell lymphoma is under the category of non-Hodgkin lymphoma. Mature T-cell lymphomas account for 10% to 15% of all lymphomas and is more common in Asia than in Europe and America. Its common subtypes include angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma and peripheral T-cell lymphoma not otherwise specified. While different subtypes have variable symptoms, common symptoms include enlarged painless lymph nodes, fever, weight loss, rash and night sweats.

References

  1. 1 2 3 4 Hamblin MR (2017). "Ultraviolet Irradiation of Blood: "The Cure That Time Forgot"?". Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology. Vol. 996. pp. 295–309. doi:10.1007/978-3-319-56017-5_25. ISBN   978-3-319-56016-8. PMC   6122858 . PMID   29124710.
  2. 1 2 3 Geynits AV, Moskvin SV, Achilov AA (2012). Внутривенное лазерное облучение крови[Intravenous laser blood irradiation] (in Russian). M.–Tver: Triada. ISBN   978-5-94789-501-8.[ page needed ]
  3. 1 2 3 Moskvin SV (2014). Effektivnost lazernoy terapii[The effectiveness of laser therapy]. Effective laser therapy (in Russian). Vol. 2. M.–Tver: Triada. ISBN   978-5-94789-636-7.[ page needed ]
  4. 1 2 Schwartz SO, Kaplan SR, Stengle J, Stevenson FL, Vincenti M (July 1952). "Ultraviolet irradiation of blood in man; studies of sixty-eight patients". Journal of the American Medical Association. 149 (13): 1180–3. doi:10.1001/jama.1952.02930300006002. PMID   14938136.
  5. Knott EK (August 1948). "Development of ultraviolet blood irradiation". American Journal of Surgery. 76 (2): 165–71. doi:10.1016/0002-9610(48)90068-3. PMID   18876742.
  6. Moshkovska T, Mayberry J (July 2005). "It is time to test low level laser therapy in Great Britain". Postgraduate Medical Journal. 81 (957): 436–41. doi:10.1136/pgmj.2004.027755. PMC   1743298 . PMID   15998818.
  7. 1 2 Wu X, Hu X, Hamblin MR (April 2016). "Ultraviolet blood irradiation: Is it time to remember "the cure that time forgot"?". Journal of Photochemistry and Photobiology B: Biology. 157: 89–96. doi:10.1016/j.jphotobiol.2016.02.007. PMC   4783265 . PMID   26894849.
  8. "Therakos CELLEX Photopheresis System". Premarket Approval (PMA). U.S. Food and Drug Administration. 21 July 2017.
  9. "UVAR CELLEX Photopheresis System". Premarket Approval (PMA). U.S. Food and Drug Administration. 20 March 2009.
  10. "ECP Immunotherapy Program". Yale School of Medicine.
  11. "Photopheresis". Yale School of Medicine.
  12. Buder, Kathrin; Zirngibl, Matthias; Bapistella, Sascha; Meerpohl, Joerg J.; Strahm, Brigitte; Bassler, Dirk; Weitz, Marcus (9 June 2022). "Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents". The Cochrane Database of Systematic Reviews. 2022 (6): CD009898. doi:10.1002/14651858.CD009898.pub4. ISSN   1469-493X. PMC   9181448 . PMID   35679154.
  13. Buder, Kathrin; Zirngibl, Matthias; Bapistella, Sascha; Meerpohl, Joerg J.; Strahm, Brigitte; Bassler, Dirk; Weitz, Marcus (27 September 2022). "Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents". The Cochrane Database of Systematic Reviews. 2022 (9): CD009759. doi:10.1002/14651858.CD009759.pub4. ISSN   1469-493X. PMC   9514720 . PMID   36166494.
  14. Russell J; Rovere A, eds. (2009). "Questionable Cancer Practices in Mexico" . American Cancer Society Complete Guide to Complementary and Alternative Cancer Therapies (2nd ed.). American Cancer Society. p. 813]. ISBN   9780944235713.
  15. Weber MH, Fussgänger-May TW (2007). "Intravenous laser blood irradiation". German Journal of Acupuncture and Related Techniques. 50 (3): 12–23. doi:10.1078/0415-6412-00282. S2CID   85179000.
  16. Harrington James, Li Junheng (1998). Biomedical optics and lasers: diagnostics and treatment: 16–18 September 1998, Beijing, China. Bellingham, Washington: SPIE. ISBN   978-0-8194-3009-0.
  17. Vetchinnikova ON, Piksin IN, Kalinin AP (2002). Extracorporeal ultraviolet blood irradiation in medicine. Moskva: Izdatelʹ Evgenii︠a︡ Razumova. p. 263. ISBN   978-5-93513-024-4.
  18. "Ultraviolet Blood Irradiation Intravenous Treatment". CA: A Cancer Journal for Clinicians. 20 (4): 248–250. 1970. doi:10.3322/canjclin.20.4.248. S2CID   221547254.